Study of Ketamine Administered Intravenously and by Sublingual Wafer
NCT01377831 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2015-03-10
Summary
To determine the rate and extent of of absorption of racemic ketamine from sublingual wafer
Conditions
Sponsors & Collaborators
-
iX Biopharma Ltd.
lead OTHER
Principal Investigators
-
Pual Rolan · Pain and Anaesthesia Research Clinic - PARC
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- Australia
Study Locations
More Related Trials
-
Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia
NCT02397356 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Single Dose Study of SHR0410 in Healthy Male Participants
NCT03493191 ·Status: COMPLETED ·Phase: PHASE1
-
Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting
NCT02303847 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
NCT05477004 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
NCT02362672 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
NCT01538745 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury
NCT01270659 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
NCT04459234 ·Status: COMPLETED
-
Plasma Concentration of Ketamine and Norketamine .
NCT02016664 ·Status: COMPLETED ·Phase: NA
-
The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
NCT05049733 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department
NCT02916927 ·Status: COMPLETED ·Phase: PHASE4
-
An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain
NCT00752661 ·Status: COMPLETED ·Phase: PHASE2
-
Intranasal Ketamine for Acute Traumatic Pain
NCT02817477 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)
NCT01780233 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Composite Biomarkers for Pain Catastrophizing
NCT04787198 ·Status: RECRUITING ·Phase: NA
-
Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain
NCT02866071 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
OBSERVATIONAL STUDY OF THE MANAGEMENT OF PATIENTS WITH CHRONIC PAIN
NCT03319238 ·Status: UNKNOWN
-
Patient Satisfaction With Subdissociative Dose Ketamine Versus Morphine for Emergency Department Pain Control
NCT04698772 ·Status: COMPLETED
-
Three Regimens of Ketamine Infusion in Complex Regional Pain Syndrome
NCT05997134 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
NCT03129347 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Ketamine for Acute Pain in the Emergency Department
NCT03017248 ·Status: UNKNOWN ·Phase: PHASE1
-
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
NCT04833816 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain
NCT03511833 ·Status: UNKNOWN ·Phase: PHASE3
-
Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis
NCT07238179 ·Status: ACTIVE_NOT_RECRUITING